- Home
- EBC vs TMDX Comparison
EBC vs TMDX Comparison
Compare EBC & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EBC | TMDX |
|---|---|---|
| Founded | 1818 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Accident &Health Insurance | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 3.9B |
| IPO Year | 2020 | 2019 |
Fundamental Metrics
Financial Performance| Metric | EBC | TMDX |
|---|---|---|
| Price | $19.53 | $134.77 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 10 |
| Target Price | $21.50 | ★ $134.80 |
| AVG Volume (30 Days) | ★ 2.1M | 803.0K |
| Earning Date | 01-22-2026 | 10-29-2025 |
| Dividend Yield | ★ 2.67% | N/A |
| EPS Growth | N/A | ★ 170.70 |
| EPS | 0.24 | ★ 2.54 |
| Revenue | ★ $627,584,000.00 | $566,354,000.00 |
| Revenue This Year | $27.03 | $38.84 |
| Revenue Next Year | $24.93 | $20.43 |
| P/E Ratio | $79.89 | ★ $53.86 |
| Revenue Growth | 3.01 | ★ 41.20 |
| 52 Week Low | $13.51 | $55.00 |
| 52 Week High | $19.49 | $156.00 |
Technical Indicators
Market Signals| Indicator | EBC | TMDX |
|---|---|---|
| Relative Strength Index (RSI) | 66.27 | 52.59 |
| Support Level | $18.40 | $133.50 |
| Resistance Level | $19.24 | $142.95 |
| Average True Range (ATR) | 0.53 | 8.39 |
| MACD | 0.12 | -0.48 |
| Stochastic Oscillator | 93.35 | 42.00 |
Price Performance
Historical ComparisonAbout EBC Eastern Bankshares Inc.
Eastern Bankshares Inc is a commercial bank that caters its products and services to retail, commercial, and small business customers. Its diversified products and services include lending, deposit, wealth management, and insurance products. The company has one operating segment; Banking business which offers a range of banking lending, savings, and small business offerings, and its wealth management and trust operations.
About TMDX TransMedics Group Inc.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.